The American Journal of Pathology
Volume 180, Issue 4 , Pages 1570-1580, April 2012

In Vivo Characterization of Mutant Myotilins

  • Etsuko Keduka

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
  • ,
  • Yukiko K. Hayashi

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
    • Corresponding Author InformationAddress reprint requests to Yukiko K. Hayashi, M.D, Ph.D., Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashicho, Kodaira, Tokyo, 187-8502, Japan
  • ,
  • Sherine Shalaby

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
  • ,
  • Hiroaki Mitsuhashi

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
    • Division of Genetics, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • ,
  • Satoru Noguchi

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
  • ,
  • Ikuya Nonaka

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
  • ,
  • Ichizo Nishino

      Affiliations

    • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan

Accepted 29 December 2011. published online 20 February 2012.

Myofibrillar myopathy (MFM) is a group of disorders that are pathologically defined by the disorganization of the myofibrillar alignment associated with the intracellular accumulation of Z-disk–associated proteins. MFM is caused by mutations in genes encoding Z-disk–associated proteins, including myotilin. Although a number of MFM mutations have been identified, it has been difficult to elucidate the precise roles of the mutant proteins. Here, we present a useful method for the characterization of mutant proteins associated with MFM. Expression of mutant myotilins in mouse tibialis anterior muscle by in vivo electroporation recapitulated both the pathological changes and the biochemical characteristics observed in patients with myotilinopathy. In mutant myotilin-expressing muscle fibers, myotilin aggregates and is costained with polyubiquitin, and Z-disk–associated proteins and myofibrillar disorganization were commonly seen. In addition, the expressed S60C mutant myotilin protein displayed marked detergent insolubility in electroporated mouse muscle, similar to that observed in human MFM muscle with the same mutation. Thus, in vivo electroporation can be a useful method for evaluating the pathogenicity of mutations identified in MFM.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; a Comprehensive Research on Disability Health and Welfare (20B-12, 20B-13) award from the Ministry of Health, Labor and Welfare; a Research on Intractable Diseases award from the Ministry of Health, Labor and Welfare; an Intramural Research Grant (23-4, 23-5, 23-6) for Neurological and Psychiatric Disorders, National Center of Neurology and Psychiatry; and a grant from the Japan Foundation for Neuroscience and Mental Health.

 Supplemental material for this article can be found at http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.12.040.

PII: S0002-9440(12)00088-0

doi:10.1016/j.ajpath.2011.12.040

The American Journal of Pathology
Volume 180, Issue 4 , Pages 1570-1580, April 2012